Mark Ogden
2010
In 2010, Mark Ogden earned a total compensation of $454.6K as Acting Vice President, Finance and Principal Financial Officer at Enzon Pharmaceuticals, a 38% increase compared to previous year.
Compensation breakdown
| Other | $454,594 |
|---|---|
| Total | $454,594 |
Ogden received $454.6K in other compensation, accounting for 100% of the total pay in 2010.
Rankings
In 2010, Mark Ogden's compensation ranked 8,044th out of 10,439 executives tracked by ExecPay. In other words, Ogden earned more than 22.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,044 out of 10,439 | 23rd |
Division Manufacturing | 2,983 out of 3,838 | 22nd |
Major group Chemicals And Allied Products | 712 out of 921 | 23rd |
Industry group Drugs | 497 out of 680 | 27th |
Industry Biological Products, Except Diagnostic Substances | 96 out of 142 | 32nd |
Source: SEC filing on April 8, 2011.
Ogden's colleagues
We found five more compensation records of executives who worked with Mark Ogden at Enzon Pharmaceuticals in 2010.
2010
Jeffrey Buchalter
Enzon Pharmaceuticals
Chief Executive Officer
2010
Ralph del Campo
Enzon Pharmaceuticals
Chief Operating Officer
2010
Ivan Horak
Enzon Pharmaceuticals
Chief Scientific Officer
2010
Paul Davit
Enzon Pharmaceuticals
Executive Vice President, Human Resources and Administration
2010
Craig Tooman
Enzon Pharmaceuticals